Xenetic Biosciences XBIO 深 沪
已收盘 09-05 16:00:00 美东时间
3.0704
-0.005
-0.17%
华盛通- 最 高3.08
- 今 开3.08
- 成交量 5817股
- 最 低 2.97
- 昨 收 3.0756
- 总市值 473.49万
- 52周最高 5.2683
- 市盈率 静 --
- 换手率 0.38%
- 52周最低 2.20
- 委 比 -83.88%
- 总股本 154.21万
- 历史最高 1074.00
- 量 比 0.33
- 振 幅 3.58%
- 历史最低 2.20
- 每 手 1
- 风险率 0.58%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Xenetic Biosciences reports Q2 results
Xenetic Biosciences press release (NASDAQ:XBIO): Q2 Net loss for the quarter ended June 30, 2025 was approximately $0.7 million. Research & development expenses for the three months ended June 30, 202...
08-13 22:16
Xenetic Biosciences Q2 EPS $(0.45) Beats $(0.65) Estimate, Sales $589.897K Miss $720.000K Estimate
Xenetic Biosciences (NASDAQ:XBIO) reported quarterly losses of $(0.45) per share which beat the analyst consensus estimate of $(0.65) by 30.77 percent. This is a 45.78 percent increase over losses of $(0.83) per share
08-13 20:09
Xenetic Biosciences Reports Improved Financial Performance
Xenetic Biosciences, Inc. ( ($XBIO) ) has released its Q2 earnings. Here is a b...
08-13 12:32
Xenetic Biosciences Announces First Patient Dosing In Exploratory Clinical Study Of Systemic DNase I In Combination With FOLFIRINOX For Advanced Or Metastatic Pancreatic Cancer
Investigator initiated exploratory clinical study being conducted in Israel pursuant to agreement with collaboration partner, PeriNessCompany evaluating systemic recombinant human DNase I (DNase I) in combination with
07-08 21:04
抢滩华贸黄金地段 迪桑特想复刻始祖鸟
转自：北京商报 高端运动品牌迪桑特在华迈出关键一步。北京商报记者从华贸中心处获悉，迪桑特已正式接手北京华贸中心原阿玛尼旗舰店1400平方米黄金铺位，创下...
06-20 00:29
Xenetic Biosciences reports Q1 results
Xenetic Biosciences press release (NASDAQ:XBIO): Q1 Net loss was approximately $0.9 million. Revenue increased by approximately $0.1 million, or 16.1%, to approximately $0.6 million during the three m...
05-14 20:21
Xenetic Biosciences Q1 EPS $(0.59) Beats $(0.72) Estimate, Sales $593.26K Miss $670.00K Estimate
Xenetic Biosciences (NASDAQ:XBIO) reported quarterly losses of $(0.59) per share which beat the analyst consensus estimate of $(0.72) by 18.06 percent. This is a 24.36 percent increase over losses of $(0.78) per share
05-14 05:58
Xenetic Biosciences Net Loss For The Year Ended December 31, 2024 Was ~$4M; Ended The Year With ~$6.2M Of Cash
Summary of Financial Results for Fiscal Year 2024Net loss for the year ended December 31, 2024 was approximately $4.0 million. Research and development expenses for the year ended December 31, 2024 decreased by
03-19 20:20
失去始祖鸟代理权 三夫户外自救
炒股就看金麒麟分析师研报，权威，专业，及时，全面，助您挖掘潜力主题机会！ 来源：北京商报 失去始祖鸟代理权或许还不算太糟糕，但失去代理权后始祖鸟的...
01-08 23:30
纺织服饰行业周报：NIKE FY25Q2业绩超市场预期
主要观点 本周Nike 发布FY25Q2（截至24/11/30）业绩，收入同比下滑 8%至 124 亿美元（货币中性口径下滑 9%），净利润同比下滑 26%至...
2024-12-21 00:00
